Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 3 4Phase 1/2 3Phase 2/3 2Phase 4 1Phase 1 1

Status

Completed 108Unknown 38Active not recruiting 18Recruiting 17Terminated 15Not yet recruiting 4Withdrawn 3Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 2NETWORK 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4

Conditions

Leukemia, Myeloid, Acute 4Neoplasm Metastasis 1

Interventions

Paclitaxel 24Oxaliplatin 24Capecitabine 24Gemcitabine 21Cisplatin 21Fluorouracil 20Drug Therapy 18Docetaxel 18Carboplatin 17pembrolizumab 15Leucovorin 15Irinotecan 15Radiotherapy 12tislelizumab 11Magnetic Resonance Spectroscopy 10Bevacizumab 10Specimen Handling 9Pemetrexed 9Radiation 8Injections 8Cetuximab 8toripalimab 7Surgical Procedures, Operative 7Radiotherapy, Intensity-Modulated 7Azacitidine 7venetoclax 6sintilimab 6Trastuzumab 6Topotecan 6Standard of Care 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Not yet recruiting × Cytarabine × Clear all
NCT07022678 2026-05-22

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Children's Oncology Group

Phase 3 Not yet recruiting
556 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07407140 2026-03-25

VAG-3+7-G

Institute of Hematology & Blood Diseases Hospital, China

Phase 3 Not yet recruiting
300 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07486479 2026-03-20

Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML

The First Affiliated Hospital of Soochow University

Phase 3 Not yet recruiting
204 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06182592 2023-12-28

A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

Phase 3 Not yet recruiting
120 enrolled
Other hematologic neoplasm

Neoplasm Metastasis, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡